<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on a 57-year-old woman with three episodes of <z:hpo ids='HP_0002140'>ischemic strokes</z:hpo> and hereditary hemorrhagic <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> (HHT) </plain></SENT>
<SENT sid="1" pm="."><plain>Tests for inherited and acquired <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> showed elevated anticardiolipin immunoglobulin (Ig)M antibodies (on three separate occasions), anti-prothrombin IgG antibodies, and the heterozygous form of factor V Leiden </plain></SENT>
<SENT sid="2" pm="."><plain>This is the first case of HHT, a <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e>, combined with factor V Leiden </plain></SENT>
<SENT sid="3" pm="."><plain>No detectable <z:hpo ids='HP_0100026'>arteriovenous malformation</z:hpo> was found and ischemic episodes, documented by computer tomography, were related to the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and possibly the carriership of <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Since aspirin provoked severe nasal <z:mp ids='MP_0001914'>hemorrhages</z:mp>, treatment with <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> was initiated after the third <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Over an 18-month follow-up, ischemic episodes were absent and we regarded oral anticoagulation as unjustifiable </plain></SENT>
</text></document>